VDRM (ViaDerma) Operating Margin %: 26.15% (As of Jun. 2012)


What is ViaDerma Operating Margin %?

ViaDerma VDRM -25.00% Operating Margin % is 26.15% as of Jun. 2012.

Operating Margin % is calculated as Operating Income divided by its Revenue. ViaDerma's Operating Income for the three months ended in Jun. 2012 was $1.52 Mil. ViaDerma's Revenue for the three months ended in Jun. 2012 was $5.82 Mil. Therefore, ViaDerma's Operating Margin % for the quarter that ended in Jun. 2012 was 26.15%.

The historical rank and industry rank for ViaDerma's Operating Margin % or its related term are showing as below:


VDRM's Operating Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.45
* Ranked among companies with meaningful Operating Margin % only.

ViaDerma's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

ViaDerma's Operating Income for the three months ended in Jun. 2012 was $1.52 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Jun. 2012 was $3.74 Mil.


ViaDerma  (OTCPK:VDRM) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


ViaDerma Operating Margin % Related Terms


ViaDerma Operating Margin % Historical Data

* Premium members only.

The historical data trend for ViaDerma's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ViaDerma Operating Margin % Chart

ViaDerma Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11
Operating Margin %
-783.33 35.10 25.31 28.95 21.25

ViaDerma Quarterly Data
Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.82 15.63 21.36 19.06 26.15

VDRM vs AOLS, RDGL, PCYN: Operating Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, ViaDerma's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ViaDerma Operating Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ViaDerma's Operating Margin % distribution charts can be found below:

* The bar in red indicates where ViaDerma's Operating Margin % falls into.



ViaDerma Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

ViaDerma's Operating Margin % for the fiscal year that ended in Dec. 2011 is calculated as

Operating Margin %=Operating Income (A: Dec. 2011 ) / Revenue (A: Dec. 2011 )
=4.039 / 19.008
=21.25 %

ViaDerma's Operating Margin % for the quarter that ended in Jun. 2012 is calculated as

Operating Margin %=Operating Income (Q: Jun. 2012 ) / Revenue (Q: Jun. 2012 )
=1.521 / 5.817
=26.15 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of 26.15% mean?
ViaDerma (VDRM) has a Operating Margin % of 26.15% as of Jun. 2012. Operating margin is the ratio of total operating income to net sales. View historical data on ViaDerma and its competitors.
Is ViaDerma's Operating Margin % too high?
ViaDerma's current Operating Margin % is 26.15%. The Drug Manufacturers industry median Operating Margin % is 7.45. ViaDerma's value of 26.15% is 251% above this industry median.
How does ViaDerma's Operating Margin % compare to AOLS and RDGL?
ViaDerma's Operating Margin % of 26.15% can be compared against companies in the Drug Manufacturers industry. The industry median Operating Margin % is 7.45. ViaDerma's value of 26.15% is 251% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.45, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ViaDerma's current Operating Margin % of 26.15% is 251% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on ViaDerma and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ViaDerma's current Operating Margin % is 26.15%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ViaDerma stock overvalued right now?
ViaDerma (VDRM) has a current Operating Margin % of 26.15%. The current Operating Margin % is 26.15% and 251% above the Drug Manufacturers industry median of 7.45. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For ViaDerma (VDRM), the current Operating Margin % is 26.15% as of Jun. 2012. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ViaDerma Business Description

Address 4640 Admiralty Way, Suite 500, Marina Del Rey, CA, USA, 90292
ViaDerma Inc is a specialty pharmaceutical company focused to bring new products to market through research and development. It is engaged in the business of manufacturing and sales of pharmaceuticals, and specifically topical antibiotics and pain management in the United States of America. Its sells under the brand name Vitastem. The Company also has products in development in the fields; anti-aging skin care, pain management, hair-loss, and toenail fungus.